ResBiotic is developing first-in-class products that aim to alleviate the neutrophilic inflammation associated with dysbiosis to improve respiratory health.
1
Funding Rounds
$3.0m
Money raised
The company ResBiotic has raised a total of $3m in funding over 1 rounds.